Novan Inc - ESG Rating & Company Profile powered by AI
Full ESG analysis of Novan Inc can be accessed by signing in. If you work at Novan Inc and you wish to use your ESG aseessment, please get in touch. The SDG rating for Novan Inc indicates the company's transparency towards the United Nations SDGs.
Novan Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 8.0, social score of 6.4 and governance score of 8.0.
7.5
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 149 | Torrent Pharmaceuticals Ltd | 7.6 | High |
| 149 | Virbac SA | 7.6 | High |
| 160 | Novan Inc | 7.5 | High |
| 160 | C4X Discovery Holdings PLC | 7.5 | High |
| 160 | Ascentage Pharma Group International | 7.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Novan Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Novan Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Novan Inc report the average age of the workforce?
Sign up for free to unlockDoes Novan Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Novan Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Novan Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Novan Inc offer flexible work?
Sign up for free to unlockDoes Novan Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Novan Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Novan Inc conduct supply chain audits?
Sign up for free to unlockDoes Novan Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Novan Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Novan Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Novan Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Novan Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Novan Inc disclose water use targets?
Sign up for free to unlockDoes Novan Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Novan Inc have a product recall in the last two years?
Sign up for free to unlockDoes Novan Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Novan Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Novan Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Novan Inc disclose parental leave metrics?
Sign up for free to unlockDoes Novan Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Novan Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Novan Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Novan Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Novan Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Novan Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Novan Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Novan Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Novan Inc disclose its waste policy?
Sign up for free to unlockDoes Novan Inc report according to TCFD requirements?
Sign up for free to unlockDoes Novan Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Novan Inc disclose energy use targets?
Sign up for free to unlockDoes Novan Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Novan Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Novan Inc
These potential risks are based on the size, segment and geographies of the company.
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.